AstraZeneca sees higher 2022 sales, but Covid boost waning
AstraZeneca forecast higher 2022 sales and raised its annual dividend for the first time in a decade on Thursday after beating fourth-quarter profit expectations, but warned the boost from its Covid-19 ...